Tivic Health Registers 400K Shares for Resale Linked to Statera Biopharma License Agreement

Tivic Health Systems is registering 400,044 shares of common stock for resale by selling stockholders, tied to the Exclusive License Agreement with Statera Biopharma. The agreement was signed on February 11 and amended on June 18, 2025. The stock issuance is a result of the agreement between the two companies.

Tivic Health Systems (NASDAQ: TIVC) has announced the registration of 400,044 shares of common stock for potential resale by selling stockholders. This move is tied to the company's Exclusive License Agreement with Statera Biopharma, which was signed on February 11 and amended on June 18, 2025 [1]. The stock issuance is a direct result of this agreement between the two companies.

The agreement between Tivic Health Systems and Statera Biopharma involves an exclusive license for a specific technology or product, which could be a significant driver for Tivic's strategic transformation. The stock issuance, therefore, is a financial mechanism to facilitate the resale of shares by existing stockholders, possibly to accommodate the financial obligations arising from the license agreement.

This development comes amidst Tivic's strategic repositioning in the market and its focus on biopharma. The company has recently expanded its intellectual property portfolio and secured $8.4 million in financing [2]. These moves indicate a broader strategic shift towards a more biopharma-centric model.

Investors should closely monitor the financial implications of this stock issuance and the broader impact of the license agreement on Tivic's financial performance and market positioning. As with any significant financial transaction, the details of the agreement and its impact on Tivic's operations and financial health will be crucial for assessing the long-term prospects of the company.

References:
[1] https://seekingalpha.com/news/4482891-tivic-health-registers-400k-shares-for-resale-linked-to-statera-license-deal
[2] https://seekingalpha.com/news/4482891-tivic-health-registers-400k-shares-for-resale-linked-to-statera-license-deal